Ecansya (previously Capecitabine Krka)
Analogs of Ecansya (previously Capecitabine Krka)
Find cheaper analogs and generic equivalents for Ecansya (previously Capecitabine Krka).
Active Ingredient: capecitabine
Product Overview
About Ecansya (previously Capecitabine Krka)
Ecansya is a cytotoxic medicine that belongs to the group 'anti-metabolites'. It is available as tablets (150, 300 and 500 mg).
What it is used for
Not available in the provided information.
How it is used
Ecansya should only be prescribed by a doctor who is qualified in the use of cancer medicines. Before starting treatment, it is recommended that patients are tested to check that they have a working dihydropyrimidine dehydrogenase (DPD) enzyme. The dose depends on the patient’s height and weight and the type of cancer being treated. Ecansya tablets should be taken within 30 minutes after a meal. The tablets are given twice daily for 14 days followed by a 7-day gap before the next course. Treatment is continued for six months after colon surgery. For other types of cancer, treatment is stopped if the disease gets worse or the side effects are unacceptable. Doses need to be adjusted for patients with liver or kidney disease and for patients who develop certain side effects. For patients with partial DPD deficiency, a lower starting dose may be considered.
How it works
The active substance in Ecansya, capecitabine, is converted to the medicine fluorouracil in the body, but more is converted in tumour cells than in normal tissues. Fluorouracil is very similar to pyrimidine. Pyrimidine is part of the genetic material of cells (DNA and RNA). In the body, fluorouracil takes the place of pyrimidine and interferes with the enzymes involved in making new DNA. As a result, it stops the growth of tumour cells and eventually kills them.
Active substance: capecitabine
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
